Professor Leslie Wolf, Distinguished University Professor and Ben F. Johnson Jr. Chair in Law at Georgia State University ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...

Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

Moments after Regeneron CEO Len Schleifer scolded analysts for asking too many questions about the disappointing sales of eye ...

BTIG analyst Ryan Zimmerman upgraded Treace Medical (TMCI) to Buy from Neutral with a $16 price target The company has pivoted away from ...